Literature DB >> 20662974

Impella Recover 5.0 assisted coronary artery bypass grafting.

Mehmet H Akay1, O H Frazier.   

Abstract

We used the Impella Recover LD 5.0 Left Ventricular Assist Device to support a 61-year-old woman with an acute myocardial infarction, compromised pulmonary function, and severe cardiovascular disease during coronary artery bypass grafting (CABG). Off-pump CABG or CABG with cardiopulmonary bypass would have been risky. Our case highlights the usefulness of the Impella Recover LD, which can be inserted into the ascending aorta via a prosthetic graft, for providing hemodynamic support during and after CABG in patients with complex cardiovascular disease.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20662974     DOI: 10.1111/j.1540-8191.2010.01071.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  4 in total

1.  Initial experience covering 50 consecutive cases of large Impella implantation at a single heart centre.

Authors:  Yukiharu Sugimura; Shintaro Katahira; Moritz Benjamin Immohr; Nihat Firat Sipahi; Arash Mehdiani; Alexander Assmann; Philipp Rellecke; Igor Tudorache; Ralf Westenfeld; Udo Boeken; Hug Aubin; Artur Lichtenberg; Payam Akhyari
Journal:  ESC Heart Fail       Date:  2021-09-04

Review 2.  Ventricular Unloading Using the ImpellaTM Device in Cardiogenic Shock.

Authors:  Adrian Attinger-Toller; Matthias Bossard; Giacomo Maria Cioffi; Gregorio Tersalvi; Mehdi Madanchi; Andreas Bloch; Richard Kobza; Florim Cuculi
Journal:  Front Cardiovasc Med       Date:  2022-03-23

3.  Successful use of the Impella Recover LP 5.0 device for circulatory support during off-pump coronary artery bypass grafting.

Authors:  Paolo Pepino; Germano Coronella; Piermario Oliviero; Mario Monaco; Vincenzo Schiavone; Filippo Finizio; Giuseppe Biondi-Zoccai; Giacomo Frati; Arturo Giordano
Journal:  Int J Surg Case Rep       Date:  2014-09-22

4.  New Surgical Circulatory Support System Outcomes.

Authors:  Danny Ramzy; Edward Soltesz; Mark Anderson
Journal:  ASAIO J       Date:  2020-07       Impact factor: 3.826

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.